{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:30:58Z","timestamp":1765888258329},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:p>Primary aldosteronism remains a leading cause of secondary hypertension, and its diagnosis and management continue to pose a challenge for clinicians. In this article, we review the diagnosis of primary aldosteronism along with its cardiovascular manifestations. Treatment is described depending on the diagnostic outcome, focusing on medical management with mineralocorticoid receptor antagonists and unilateral adrenalectomy. Although screening and diagnosing hyperaldosteronism follows well-known algorithms, in practice, physicians may find difficulty establishing the best course of action due to complexity in testing and confirming laterality of aldosterone production by the adrenals. Recognizing and treating primary aldosteronism requires a multidisciplinary approach with primary care physicians, cardiologists, endocrinologists, and radiologists working collaboratively.<\/jats:p>","DOI":"10.1097\/crd.0000000000000281","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T08:56:00Z","timestamp":1577091360000},"page":"84-91","source":"Crossref","is-referenced-by-count":16,"title":["Primary Aldosteronism"],"prefix":"10.1097","volume":"28","author":[{"given":"Padma Raghavan","family":"Pillai","sequence":"first","affiliation":[{"name":"From the Division of Endocrinology, Department of Medicine, Westchester Medical Center at New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Griffith","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology, Department of Medicine, Westchester Medical Center at New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica D.","family":"Schwarcz","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology, Department of Medicine, Westchester Medical Center at New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene A.","family":"Weiss","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology, Department of Medicine, Westchester Medical Center at New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-44-1-1","article-title":"Primary aldosteronism, a new clinical entity.","volume":"44","author":"Conn","year":"1956","journal-title":"Ann Intern Med"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis.","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IBPC.S13783","article-title":"Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine.","volume":"6","author":"Funder","year":"2013","journal-title":"Integr Blood Press Control"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1172\/JCI7840","article-title":"Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney.","volume":"104","author":"Masilamani","year":"1999","journal-title":"J Clin Invest"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1681\/ASN.2016020124","article-title":"Coordinated control of ENaC and Na+,K+-ATPase in renal collecting duct.","volume":"27","author":"Feraille","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1042\/BCJ20160312","article-title":"The sodium chloride cotransporter (NCC) and epithelial sodium channel (ENaC) associate.","volume":"473","author":"Mistry","year":"2016","journal-title":"Biochem J"},{"issue":"2 Pt 2","key":"R7-20230903","first-page":"I183","article-title":"Role of renal hemodynamics and arterial pressure in aldosterone \u201cescape.\u201d","volume":"6","author":"Hall","year":"1984","journal-title":"Hypertension"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.","volume":"97","author":"Monticone","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.crd.0000096417.42861.ce","article-title":"Glucocorticoid-remediable aldosteronism.","volume":"12","author":"McMahon","year":"2004","journal-title":"Cardiol Rev"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152506775268776","article-title":"Mineralocorticoid receptor blockade in the protection of target organ damage.","volume":"4","author":"Mulatero","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.HYP.29.3.723","article-title":"Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.","volume":"29","author":"Shigematsu","year":"1997","journal-title":"Hypertension"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1210\/jc.2011-0354","article-title":"Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.","volume":"96","author":"Pimenta","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry.","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","article-title":"Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan.","volume":"71","author":"Ohno","year":"2018","journal-title":"Hypertension"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline.","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease.","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension.","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"R23-20230903","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on adrenal tumors of the Italian Society of Endocrinology.","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3904\/kjim.2005.20.4.303","article-title":"Clinical study of adrenal incidentaloma in Korea.","volume":"20","author":"Kim","year":"2005","journal-title":"Korean J Intern Med"},{"key":"R25-20230903","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism.","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/jhh.2011.47","article-title":"Resistant hypertension, obstructive sleep apnoea and aldosterone.","volume":"26","author":"Dudenbostel","year":"2012","journal-title":"J Hum Hypertens"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.117.10405","article-title":"Primary aldosteronism and cardiovascular events: it is time to take guideline recommendations seriously.","volume":"71","author":"Reincke","year":"2018","journal-title":"Hypertension"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.2004-1149","article-title":"The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling.","volume":"90","author":"Tiu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ancard.2015.04.017","article-title":"Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension.","volume":"64","author":"Barigou","year":"2015","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism.","volume":"101","author":"Baudrand","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism.","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R34-20230903","first-page":"39","article-title":"Laboratory investigation of primary aldosteronism.","volume":"31","author":"Stowasser","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"R35-20230903","first-page":"1685","article-title":"Aldosterone-producing-adenoma (A-P-A): effect of pregnancy.","volume":"4","author":"Gordon","year":"1982","journal-title":"Clin Exp Hypertens A"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/clpt.1980.221","article-title":"Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney.","volume":"28","author":"Mitnick","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/pgmj.75.882.235","article-title":"Calcium-channel blockade can mask the diagnosis of conn\u2019s syndrome.","volume":"75","author":"Brown","year":"1999","journal-title":"Postgrad Med J"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism.","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"R39-20230903","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jacc.2007.10.027","article-title":"Renin inhibition in hypertension.","volume":"51","author":"Gradman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-63-4-1008","article-title":"Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.","volume":"63","author":"Derkx","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-20230903","first-page":"939","article-title":"Malignant hypertension due to an aldosterone producing adrenal adenoma.","volume":"7","author":"Murphy","year":"1985","journal-title":"Clin Exp Hypertens A"},{"key":"R42-20230903","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.amjhyper.2007.02.018","article-title":"The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.","volume":"20","author":"van den Born","year":"2007","journal-title":"Am J Hypertens"},{"key":"R43-20230903","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ando.2016.01.007","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 3: confirmatory testing.","volume":"77","author":"Reznik","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"R44-20230903","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study.","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"key":"R45-20230903","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/jc.2011-2504","article-title":"Confirmatory testing in primary aldosteronism.","volume":"97","author":"Nanba","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-20230903","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","article-title":"Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood.","volume":"138","author":"Dluhy","year":"2001","journal-title":"J Pediatr"},{"key":"R47-20230903","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma.","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-20230903","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.2342031876","article-title":"Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.","volume":"234","author":"Szolar","year":"2005","journal-title":"Radiology"},{"key":"R49-20230903","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1677\/ERC-07-0045","article-title":"The optimal imaging of adrenal tumours: a comparison of different methods.","volume":"14","author":"Ilias","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R50-20230903","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/jc.2007-2055","article-title":"Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes.","volume":"93","author":"Mulatero","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-20230903","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism.","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"R52-20230903","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R53-20230903","first-page":"89","article-title":"Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures.","volume":"24","author":"Jakobsson","year":"2018","journal-title":"Diagn Interv Radiol"},{"key":"R54-20230903","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-20230903","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-18-0328","article-title":"Radiation exposure of adrenal vein sampling: a German Multicenter Study.","volume":"179","author":"Fuss","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R56-20230903","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1245\/s10434-011-2121-5","article-title":"What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?","volume":"19","author":"Webb","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R57-20230903","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism.","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-20230903","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1210\/jc.2017-01774","article-title":"Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism.","volume":"103","author":"Umakoshi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-20230903","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/EJE-17-0990","article-title":"Management of endocrine disease: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.","volume":"179","author":"Williams","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R60-20230903","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.17219\/acem\/69390","article-title":"Genetic aspects of primary hyperaldosteronism.","volume":"27","author":"Korzy\u0144ska","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"R61-20230903","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R62-20230903","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/bjs.4738","article-title":"Laparoscopic adrenalectomy.","volume":"91","author":"Assalia","year":"2004","journal-title":"Br J Surg"},{"key":"R63-20230903","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(17)30368-6","article-title":"Primary aldosteronism and cardiovascular risk, before and after treatment.","volume":"6","author":"Funder","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R64-20230903","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12902-017-0209-z","article-title":"Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis.","volume":"17","author":"Zhou","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"R65-20230903","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of aldosteronism after target treatments.","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"R66-20230903","doi-asserted-by":"crossref","first-page":"104","DOI":"10.9738\/CC140.1","article-title":"Predictors of successful outcome after adrenalectomy for primary aldosteronism.","volume":"97","author":"Wang","year":"2012","journal-title":"Int Surg"},{"key":"R67-20230903","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00268-016-3822-5","article-title":"Hypertension cure following laparoscopic adrenalectomy for hyperaldosteronism is not universal: trends over two decades.","volume":"41","author":"Namekawa","year":"2017","journal-title":"World J Surg"},{"key":"R68-20230903","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0030-1252060","article-title":"What we still do not know about adrenal vein sampling for primary aldosteronism.","volume":"42","author":"Auchus","year":"2010","journal-title":"Horm Metab Res"},{"key":"R69-20230903","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1210\/jc.2014-3676","article-title":"Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study.","volume":"100","author":"Wolley","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R70-20230903","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1507\/endocrj.EJ13-0353","article-title":"Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study.","volume":"61","author":"Miyake","year":"2014","journal-title":"Endocr J"},{"key":"R71-20230903","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing outcome of surgery for primary aldosteronism.","volume":"131","author":"Celen","year":"1996","journal-title":"Arch Surg"},{"key":"R72-20230903","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.surg.2014.08.021","article-title":"Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism.","volume":"156","author":"Wachtel","year":"2014","journal-title":"Surgery"},{"key":"R73-20230903","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"R74-20230903","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.","volume":"98","author":"Fischer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R75-20230903","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1097\/HJH.0000000000001476","article-title":"Microalbuminuria and plasma aldosterone levels in nondiabetic treatment-na\u00efve patients with hypertension.","volume":"35","author":"Catena","year":"2017","journal-title":"J Hypertens"},{"key":"R76-20230903","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism.","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R77-20230903","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension.","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"R78-20230903","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R79-20230903","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R80-20230903","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism.","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"R81-20230903","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"R82-20230903","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment.","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"R83-20230903","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term.","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"R84-20230903","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment.","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R85-20230903","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism.","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"R86-20230903","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism.","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:11:17Z","timestamp":1693732277000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000281"}},"subtitle":["Cardiovascular Risk, Diagnosis, and Management"],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000281","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}